Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
DATE PUBLISHED: 2022 Nov 03
JOURNAL:J AOAC Int
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/36326356?dopt=Abstract
Amigrain®, the market formulation of the ternary mixture of analgin, caffeine, and ergotamine is used for the symptomatic treatment of migraine.
